Table 2.
The LV echocardiographic characteristics of the studied groups.
| Active RA (n = 81) | Remission RA (n = 39) | Control | p-Value | |
|---|---|---|---|---|
| LV septum thickness at end diastole | 0.93 ± 0.09 | 0.94 ± 0.10 | 0.94 ± 0.10 | 0.766 |
| LV PW thickness at end diastole | 0.99 ± 0.79 | 0.90 ± 0.09 | 0.91 ± 0.08 | 0.614 |
| LVEDV | 121.59 ± 17.70 | 117.41 ± 15.58 | 118.30 ± 20.39 | 0.413 |
| LVESV | 46.58 ± 10.69 | 42.44 ± 9.52 | 42.50 ± 11.59 | 0.054 |
| EF% | 62.11 ± 5.06 | 63.33 ± 5.51 | 63.70 ± 5.36 | 0.229 |
| Mitral Peak E (m/s) | 0.77 ± 0.10 | 0.78 ± 0.10 | 0.80 ± 0.11 | 0.193 |
| Mitral Peak A (m/s) | 0.77 ± 0.10 | 0.73 ± 0.11 | 0.74 ± 0.11 | 0.077 |
| LV IVRT (ms) | 87.32 ± 11.17 | 85.77 ± 16.16 | 82.15 ± 9.73 | 0.096 |
| Mitral E/è | 11.04 ± 1.50 | 11.69 ± 1.62 | 11.20 ± 1.62 | 0.101 |
| Peak S′ (cm/s) | 10.99 ± 1.38 | 10.92 ± 1.40 | 11.43 ± 1.41 | 0.196 |
| LV GLS (%) | −18.56 ± 1.87 | −21.18 ± 1.27a | −20.78 ± 1.44a | <0.001 for active vs control and active vs remission and 0.027 for remission vs control |
All data are represented as mean ± SD and number (percent).
a: significant with active group, b: significant with Remission group.
RA, rheumatoid arthritis; LV, left ventricular; LVEDV, left ventricular end-diastolic volume index; LVESV = left ventricular end-systolic volume; EF%, Ejection fraction; E: peak flow velocity during the early rapid filling phase; A: peak flow velocity during atrial contraction; IVRT, Isovolumic relaxation time; E/ è, the ratio of early flow velocity to the early annular velocity; S′=systolic annulus velocity; GLS, global longitudinal strain.